Pharmafile Logo
Pharmafocus logo
Advanced Search

par

Showing 15 posts of 27 posts found.

amgen_flag

FDA says no to Amgen’s Parsabiv

August 25, 2016
Research and Development, Sales and Marketing Amgen, FDA, par

Amgen has announced that the US Food and Drug Administration (FDA) has issued a complete response letter rejecting Parsabiv (etelcalcetide) …

News

NICE approves Sutent but rejects rivals

February 4, 2009
Sales and Marketing NICE, par

NICE has approved Pfizer's Sutent but rejected three other treatments for kidney cancer. The decision is one of the first …

News

Green light for kidney cancer drugs in Wales

January 26, 2009
Sales and Marketing NHS, par, rcc

Kidney cancer patients in Wales are to gain access to the four new drugs that are still denied on the …

News

Sutent to be first to benefit from NICE reform

January 20, 2009
Sales and Marketing NICE, par

Sutent and other rival treatments for renal cell carcinoma look set to be the first drugs to benefit from reforms …

News

Postcode prescribing to persist warn MPs

January 20, 2009
NHS, par

The draft NHS Constitution will not help end the postcode lottery surrounding access to drugs, the Health Select Committee has …

News

Revlimid talks confirm shift in approach to pricing

January 20, 2009
Sales and Marketing NICE, par

Celgene is in negotiations to agree a deal to make its cancer drug Revlimid more affordable to the NHS and …

News

UK pharma to lose

January 8, 2009
Sales and Marketing ABPI, NHS, par

The UK pharmaceutical industry stands to lose £225 million in annual profits under its new pricing agreement with the government. …

News

PMCPA cautions on the way new prices are promoted

January 7, 2009
Sales and Marketing par, reg

UK pharma companies have been warned not to mislead doctors about new lower prices of medicines. Code of Practice regulator …

News

NICE makes end-of-life drugs more available

January 6, 2009
Sales and Marketing NICE, par

High-cost drugs that extend the lives of terminally ill patients will be more readily approved for NHS use, thanks to …

News

SMC criticises PPRS prescribing incentives

December 5, 2008
Sales and Marketing NICE, par

The government move to incentivise doctors for the prescription of new innovative medicines has been criticised by the Scottish Medicines …

News

Flexible pricing PPRS hailed as a ‘landmark’ deal

November 21, 2008
Sales and Marketing ABPI, par

The future of UK medicines could be revolutionised by a new deal that contains two pioneering measures on flexible prices …

News

Government and pharma reach PPRS deal

November 19, 2008
Sales and Marketing ABPI, par

The UK government has agreed a new flexible pricing deal with the industry, in which companies can raise the price …

News

UK set for new flexible drug pricing, says Johnson

November 14, 2008
Sales and Marketing NHS, par

The government is working with the pharma industry on new 'flexible pricing' arrangements, even though revisions to the existing PPRS …

News

Government delays PPRS to maximise savings

November 12, 2008
Sales and Marketing ABPI, par

The PPRS deal agreed in principle this summer has been now thrown into confusion by government, with its launch at …

News

Pharma and NICE must end games of ‘one-upmanship’

November 10, 2008
Sales and Marketing NHS, par

Patient groups are calling on a pharmaceutical company to reach a compromise with NICE over a bone marrow cancer drug. …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026